Jean-Paul Ansel

GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium.

EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium.

PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Accessia Pharma SA is a Belgian company that focuses on manufacturing products according to the needs of their clients. The company is based in Herstal, Belgium. The company provides tools and resources to help their clients benefit from economies of scale. Benjamin Boinem has been the CEO of the company since 2015.

Fluxys SA is an independent energy infrastructure group based in Brussels, Belgium with 1,300 employees. The Belgian company is active in gas transmission and storage, as well as liquefied natural gas terminalling. Fluxys operates 12,000 kilometers of pipeline and liquefied natural gas terminals with a yearly regasification capacity of 29 billion cubic meters. The company's purpose is to contribute to a better society by shaping a bright energy future. Fluxys is committed to transporting hydrogen, biomethane, or any other carbon-neutral energy carrier, as well as CO2, accommodating the capture, usage, and storage of the latter. The company was founded in 2008, and the CEOs are Walter Peeraer and Pascal de Buck.

Cometsambre SA the recycling of ferrous metals is one of the COMET Group's main activities, performed through Cometsambre SA, and also forms the main axis for development and expansion. The growth of COMETSAMBRE means that they now handle a supply of almost 1 000 000 tones of scrap iron per year, making they the biggest producer of iron and steel industry materials in Belgium. The principles constantly applied in its management, expansion, commercial and operational pro-activity and technological expertise make COMETSAMBRE a leading company in the world of ferrous metal recycling. They are a serious partner, guaranteeing product quality, and respect for environmental standards-technical performance for recycling.

Serum Institute of India Pvt Ltd. engages in the production and exportation of anti-cancer products and viral vaccines. Its products include bacterial vaccines, recombinant and combination vaccines, viral vaccines, influenza vaccines. uro-oncology, and polysaccharide conjugate vaccine. The company was founded by Cyrus S. Poonawalla in 1966 and is headquartered in Pune, India.